Bulletin 2011/27 - European Patent Office
10.12.2012 • Views
Share Embed Flag

Bulletin 2011/27 - European Patent Office

Bulletin 2011/27 - European Patent Office

Bulletin 2011/27 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

START NOW

(A61K) II.1(1)<br />

(51) A61K 31/397 (11) 1 877 050 B1<br />

C07D 205/08 A61P 1/00<br />

(25) En (26) En<br />

(21) 06758920.0 (22) 02.05.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 16.01.2008<br />

(86) US 2006/016804 02.05.2006<br />

(87) WO 2006/121708 2006/46 16.11.2006<br />

(30) 06.05.2005 US 678402 P<br />

(54) • SUBSTITUIERTE BETA-LACTAME UND<br />

DEREN VERWENDUNG IN DER MEDIZIN<br />

• SUBSTITUTED BETA-LACTAMS AND<br />

THEIR USE IN MEDICINE<br />

• BETA-LACTAMINES SUBSTITUEES AINSI<br />

QUE LEUR UTILISATION EN MEDECINE<br />

(73) ALLERGAN, INC., 2525 Dupont Drive, Irvine<br />

CA 92612, US<br />

(72) OLD, David, W., Irvine, California 92620, US<br />

(74) HOFFMANN EITLE, <strong>Patent</strong>- und Rechtsanwälte<br />

Arabellastraße 4, 81925 München, DE<br />

A61K 31/40 → (51) C07C 317/22<br />

A61K 31/415 → (51) C07D 233/72<br />

A61K 31/4155 → (51) C07D 413/12<br />

(51) A61K 31/4184 (11) 1 940 396 B1<br />

A01N 43/52 A61P 33/10<br />

A01N 43/04 A61K 9/08<br />

(25) En (26) En<br />

(21) 05790713.1 (22) 15.09.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

AL BA HR MK YU<br />

(43) 09.07.2008<br />

(86) NZ 2005/000243 15.09.2005<br />

(87) WO 2007/032688 2007/12 22.03.2007<br />

(54) • ANTHELMINTISCHE FORMULIERUNGEN<br />

• ANTHELMINTIC FORMULATIONS<br />

• COMPOSITIONS AUX ANTHELMINTHI-<br />

QUES<br />

(73) Merial Limited, P.O.Box 3<strong>27</strong> Sandringham<br />

House Sandringham Avenue Harlow Business<br />

Park, Harlow, Essex CM19 5TG, GB<br />

(72) RAZZAK, Majid Hameed Abdul, Auckland,<br />

1309, NZ<br />

(74) Harding, Charles Thomas, D Young & Co<br />

LLP 120 Holborn, London EC1N 2DY, GB<br />

A61K 31/4192 → (51) A61P <strong>27</strong>/02<br />

A61K 31/4245 → (51) A61K 31/662<br />

A61K 31/4453 → (51) C07C 317/22<br />

A61K 31/454 → (51) C07D 401/06<br />

A61K 31/4704 → (51) C07D 215/18<br />

A61K 31/495 → (51) C07D 295/073<br />

A61K 31/496 → (51) C07D 401/06<br />

A61K 31/50 → (51) A61P 35/00<br />

A61K 31/501 → (51) A61P 35/00<br />

A61K 31/551 → (51) A61K 31/662<br />

(51) A61K 31/59 (11) 1 064 000 B1<br />

(25) En (26) En<br />

(21) 99914109.6 (22) 25.03.1999<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(43) 03.01.2001<br />

(86) US 1999/006442 25.03.1999<br />

(87) WO 1999/049870 1999/40 07.10.1999<br />

(30) <strong>27</strong>.03.1998 US 79696 P<br />

(54) • VITAMIN D UND DESSEN ANALOGE ZUR<br />

BEHANDLUNG VOM TUMOREN UND<br />

ANDEREN HYPERPROLIFERATIVEN<br />

ERKRANKUNGEN<br />

• VITAMIN D AND ITS ANALOGS IN THE<br />

TREATMENT OF TUMORS AND OTHER<br />

HYPERPROLIFERATIVE DISORDERS<br />

• VITAMINE D ET SES ANALOGUES POUR<br />

LE TRAITEMENT DE TUMEURS ET D'AU-<br />

TRES TROUBLES D'HYPERPROLIFERA-<br />

TION<br />

(73) Oregon Health & Science University, 3181 S.<br />

W. Sam Jackson Park Road, Portland, OR<br />

97201-3098, US<br />

(72) HENNER, William, D., Portland, OR 97221,<br />

US<br />

BEER, Tomasz, M., Portland, OR 97215, US<br />

(74) Schlich, George William, et al, Schlich & Co<br />

34 New Road, Littlehampton West Sussex<br />

BN17 5AT, GB<br />

(60) 10184333.2<br />

(51) A61K 31/662 (11) 1 434 588 B1<br />

A61K 31/197 A61K 31/4245<br />

A61K 31/198 A61K 31/551<br />

A61P 25/04<br />

(25) En (26) En<br />

(21) 0<strong>27</strong>89180.3 (22) 09.10.2002<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR IE IT LI LU MC NL PT SE SK TR<br />

AL LT LV MK RO SI<br />

(43) 07.07.2004<br />

(86) US 2002/032252 09.10.2002<br />

(87) WO 2003/031416 2003/16 17.04.2003<br />

(30) 10.10.2001 US 328245 P<br />

(54) • 2-(AMINO-3,4-DIOXO-1-CYCLOBUTEN-1-<br />

YL)AMINOALKYLSÄURE-DERIVATE FÜR<br />

DIE SCHMERZBEHANDLUNG<br />

• 2-(AMINO-3,4-DIOXO-1CYCLOBUTEN-1-<br />

YL)AMINO ALKYL -ACID DERIVATIVES<br />

FOR THE TREATMENT OF PAIN<br />

• DERIVES DE L'ACIDE 2-(AMINO-3,4-<br />

DIOXO-1CYCLOBUTENE-1-YL)AMINO<br />

ALKYL UTILES DANS LE TRAITEMENT DE<br />

LA DOULEUR<br />

(73) Wyeth LLC, Five Giralda Farms, Madison, NJ<br />

07940, US<br />

(72) BRANDT, Michael, Richard, Flemington, NJ<br />

08822, US<br />

ZALESKA, Margaret, Maria, Narberth, PA<br />

19072, US<br />

MOYER, John, Allen, New Hope, PA 18938,<br />

US<br />

(74) Brunetti, Fabrizio, et al, Pfizer Limited<br />

<strong>European</strong> <strong>Patent</strong> Department Ramsgate<br />

Road, Sandwich, Kent CT13 9NJ, GB<br />

A61K 31/7088 → (51) C07K 16/24<br />

A61K 31/712 → (51) C07H 21/00<br />

A61K 31/7125 → (51) C07H 21/00<br />

A61K 31/7125 → (51) C12N 15/113<br />

A61K 35/74 → (51) A23L 1/30<br />

(51) A61K 38/17 (11) 1 415 659 B1<br />

A61K 39/395 A61K 48/00<br />

A61P 9/00 A61P 9/12<br />

A61P 13/12 A61P 35/00<br />

A61P 31/18 A61P 37/02<br />

(25) En (26) En<br />

(21) 03018879.1 (22) 25.01.2000<br />

4<strong>27</strong><br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>27</strong>/<strong>2011</strong>) 06.07.<strong>2011</strong><br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE<br />

(43) 06.05.2004<br />

(30) 25.01.1999 US 117169 P<br />

09.07.1999 US 143228 P<br />

(54) • Verwendung eines Antikörpers gegen<br />

wasserlöslich BAFF zur Krebsbehandlung<br />

• An antibody specific for soluble BAFF for<br />

use in the treatment of cancer<br />

• Utilisation d'un anticorps dirigé contre<br />

BAFF soluble dans le traitement du cancer<br />

(73) Biogen Idec MA Inc., 14 Cambridge Center,<br />

Cambridge, Massachusetts 02142, US<br />

Apoxis SA, 22, chemin des Croisettes, 1066<br />

Epalinges, CH<br />

(72) Browning, Jeffrey, Brookline, MA 02146, US<br />

Ambrose, Christine, Reading, MA 01867, US<br />

MacKay, Fabienne, Vaucluse NSW 2030, AU<br />

Tschopp, Jurg, 1066 Epalinges, CH<br />

Schneider, Pascal, 1066 Epalinges, CH<br />

(74) Pohlman, Sandra M., et al, df-mp Fünf Höfe<br />

Theatinerstrasse 16, 80333 München, DE<br />

(60) 10180420.1 / 2 298 332<br />

10181337.6 / 2 319 5<strong>27</strong><br />

(62) 00909970.6 / 1 146 892<br />

A61K 38/17 → (51) A61K 39/395<br />

A61K 38/17 → (51) C07K 14/705<br />

A61K 38/17 → (51) C07K 14/715<br />

A61K 38/17 → (51) C07K 16/24<br />

(51) A61K 38/18 (11) 1 763 362 B1<br />

A61P 19/02<br />

(25) En (26) En<br />

(21) 05753766.4 (22) 24.05.2005<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

(43) 21.03.2007<br />

(86) US 2005/018020 24.05.2005<br />

(87) WO 2005/115438 2005/49 08.12.2005<br />

(30) 25.05.2004 US 574423 P<br />

(54) • VERWENDUNG VON OP-1 ZUR BEHAND-<br />

LUNG VON KNORPELDEFEKTEN<br />

• USE OF OP-1 FOR TREATING CARTILAGE<br />

DEFECTS<br />

• UTILISATION D'OP-1S POUR TRAITER<br />

LES ANOMALIES DES CARTILAGES<br />

(73) STRYKER CORPORATION, 2825 Airview<br />

Boulevard, Kalamazoo, MI 49002, US<br />

(72) RUEGER, David, C., Southborough, MA<br />

01772, US<br />

KILDEY, Robyn, Balmain, Sidney, New South<br />

Wales 2041, AU<br />

(74) Vossius & Partner, Siebertstrasse 4, 81675<br />

München, DE<br />

(60) 10179674.6 / 2 298 335<br />

A61K 38/19 → (51) C07K 14/715<br />

(51) A61K 38/20 (11) 1 689 775 B1<br />

(25) En (26) En<br />

(21) 04801190.2 (22) 02.12.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU MC NL PL PT RO SE<br />

SI SK TR<br />

AL BA HR LV MK YU<br />

(43) 16.08.2006<br />

(86) EP 2004/013670 02.12.2004<br />

(87) WO 2005/054285 2005/24 16.06.2005<br />

(30) 04.12.2003 AT 19522003<br />

(54) • GAG-bindende Proteine<br />

• GAG binding proteins<br />

• Protéines de liaison aux GAG

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!